Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
PCR Amplification of Highly GC-Rich Regions.

CSH protocols

Lotte Hansen L, Justesen J.
PMID: 22485497
CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4093.

No abstract available.

Cite
Lotte Hansen L, Justesen J. PCR Amplification of Highly GC-Rich Regions. CSH Protoc. 2006;2006(1)doi: 10.1101/pdb.prot4093.
Lotte Hansen, L., & Justesen, J. (2006). PCR Amplification of Highly GC-Rich Regions. CSH protocols, 2006(1), . https://doi.org/10.1101/pdb.prot4093
Lotte Hansen, Lise, and Justesen, Just. "PCR Amplification of Highly GC-Rich Regions." CSH protocols vol. 2006,1 (2006). doi: https://doi.org/10.1101/pdb.prot4093
Lotte Hansen L, Justesen J. PCR Amplification of Highly GC-Rich Regions. CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4093. PMID: 22485497.
Copy Download .nbib Format: NLM
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer.

Nature biotechnology

Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A.
PMID: 34663921
Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18.

Tumor-associated epitopes presented on MHC-I that can activate the immune system against cancer cells are typically identified from annotated protein-coding regions of the genome, but whether peptides originating from novel or unannotated open reading frames (nuORFs) can contribute to...

Cite
Ouspenskaia T, Law T, Clauser KR, et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021;doi: 10.1038/s41587-021-01021-3.
Ouspenskaia, T., Law, T., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., Hartigan, C. R., Keshishian, H., Apffel, A., Oliveira, G., Zhang, W., Chen, S., Chow, Y. T., Ji, Z., Jungreis, I., Shukla, S. A., Justesen, S., Bachireddy, P., Kellis, M., Getz, G., Hacohen, N., Keskin, D. B., Carr, S. A., Wu, C. J., & Regev, A. (2021). Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nature biotechnology, . https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia, Tamara, et al. "Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer." Nature biotechnology vol. (2021). doi: https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18. PMID: 34663921.
Copy Download .nbib Format: NLM
Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS.

Proteomics

Khan A, Shin JY, So MK, Na JH, Justesen S, Ansari AA, Ko BJ, Ahn SM.
PMID: 34561969
Proteomics. 2021 Sep 24;e2100171. doi: 10.1002/pmic.202100171. Epub 2021 Sep 24.

Human leukocyte antigen (HLA) class I has more than 18,000 alleles, each of which binds to a set of unique peptides from the cellular degradome. Deciphering the interaction between antigenic peptides and HLA proteins is crucial for understanding immune...

Cite
Khan A, Shin JY, So MK, et al. Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics. 2021;e2100171doi: 10.1002/pmic.202100171.
Khan, A., Shin, J. Y., So, M. K., Na, J. H., Justesen, S., Ansari, A. A., Ko, B. J., & Ahn, S. M. (2021). Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics, e2100171. https://doi.org/10.1002/pmic.202100171
Khan, Amir, et al. "Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS." Proteomics vol. (2021): e2100171. doi: https://doi.org/10.1002/pmic.202100171
Khan A, Shin JY, So MK, Na JH, Justesen S, Ansari AA, Ko BJ, Ahn SM. Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics. 2021 Sep 24;e2100171. doi: 10.1002/pmic.202100171. Epub 2021 Sep 24. PMID: 34561969.
Copy Download .nbib Format: NLM
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer.

Nature biotechnology

Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A.
PMID: 34663921
Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18.

Tumor-associated epitopes presented on MHC-I that can activate the immune system against cancer cells are typically identified from annotated protein-coding regions of the genome, but whether peptides originating from novel or unannotated open reading frames (nuORFs) can contribute to...

Cite
Ouspenskaia T, Law T, Clauser KR, et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021;doi: 10.1038/s41587-021-01021-3.
Ouspenskaia, T., Law, T., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., Hartigan, C. R., Keshishian, H., Apffel, A., Oliveira, G., Zhang, W., Chen, S., Chow, Y. T., Ji, Z., Jungreis, I., Shukla, S. A., Justesen, S., Bachireddy, P., Kellis, M., Getz, G., Hacohen, N., Keskin, D. B., Carr, S. A., Wu, C. J., & Regev, A. (2021). Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nature biotechnology, . https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia, Tamara, et al. "Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer." Nature biotechnology vol. (2021). doi: https://doi.org/10.1038/s41587-021-01021-3
Ouspenskaia T, Law T, Clauser KR, Klaeger S, Sarkizova S, Aguet F, Li B, Christian E, Knisbacher BA, Le PM, Hartigan CR, Keshishian H, Apffel A, Oliveira G, Zhang W, Chen S, Chow YT, Ji Z, Jungreis I, Shukla SA, Justesen S, Bachireddy P, Kellis M, Getz G, Hacohen N, Keskin DB, Carr SA, Wu CJ, Regev A. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat Biotechnol. 2021 Oct 18; doi: 10.1038/s41587-021-01021-3. Epub 2021 Oct 18. PMID: 34663921.
Copy Download .nbib Format: NLM
Variation in the expression of Hsp70, the major heat-shock protein, and thermotolerance in larval and adult selection lines of Drosophila melanogaster.

Journal of thermal biology

Lansing E, Justesen J, Loeschcke V.
PMID: 10880868
J Therm Biol. 2000 Dec 01;25(6):443-450. doi: 10.1016/s0306-4565(00)00008-5.

(1) Lines of Drosophila melanogaster were "laboratory naturally" or artificially selected under five thermal regimes. (2) Hsp70 expression per unit protein after heat hardening and heat-shock resistance with and without prior hardening were measured. (3) Differences between the selection...

Cite
Lansing E, Justesen J, Loeschcke V. Variation in the expression of Hsp70, the major heat-shock protein, and thermotolerance in larval and adult selection lines of Drosophila melanogaster. J Therm Biol. 2000;25(6):443-450doi: 10.1016/s0306-4565(00)00008-5.
Lansing, E., Justesen, J., & Loeschcke, V. (2000). Variation in the expression of Hsp70, the major heat-shock protein, and thermotolerance in larval and adult selection lines of Drosophila melanogaster. Journal of thermal biology, 25(6), 443-450. https://doi.org/10.1016/s0306-4565(00)00008-5
Lansing, et al. "Variation in the expression of Hsp70, the major heat-shock protein, and thermotolerance in larval and adult selection lines of Drosophila melanogaster." Journal of thermal biology vol. 25,6 (2000): 443-450. doi: https://doi.org/10.1016/s0306-4565(00)00008-5
Lansing E, Justesen J, Loeschcke V. Variation in the expression of Hsp70, the major heat-shock protein, and thermotolerance in larval and adult selection lines of Drosophila melanogaster. J Therm Biol. 2000 Dec 01;25(6):443-450. doi: 10.1016/s0306-4565(00)00008-5. PMID: 10880868.
Copy Download .nbib Format: NLM
Loss of heterozygosity: a multiplex PCR method to define a narrow deleted chromosomal region of a tumor genome.

CSH protocols

Hansen L, Justesen J.
PMID: 22485520
CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4117.

No abstract available.

Cite
Hansen L, Justesen J. Loss of heterozygosity: a multiplex PCR method to define a narrow deleted chromosomal region of a tumor genome. CSH Protoc. 2006;2006(1)doi: 10.1101/pdb.prot4117.
Hansen, L., & Justesen, J. (2006). Loss of heterozygosity: a multiplex PCR method to define a narrow deleted chromosomal region of a tumor genome. CSH protocols, 2006(1), . https://doi.org/10.1101/pdb.prot4117
Hansen, Lise, and Justesen, Just. "Loss of heterozygosity: a multiplex PCR method to define a narrow deleted chromosomal region of a tumor genome." CSH protocols vol. 2006,1 (2006). doi: https://doi.org/10.1101/pdb.prot4117
Hansen L, Justesen J. Loss of heterozygosity: a multiplex PCR method to define a narrow deleted chromosomal region of a tumor genome. CSH Protoc. 2006 Jun 01;2006(1). doi: 10.1101/pdb.prot4117. PMID: 22485520.
Copy Download .nbib Format: NLM
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.

Nature

Caushi JX, Zhang J, Ji Z, Vaghasia A, Zhang B, Hsiue EH, Mog BJ, Hou W, Justesen S, Blosser R, Tam A, Anagnostou V, Cottrell TR, Guo H, Chan HY, Singh D, Thapa S, Dykema AG, Burman P, Choudhury B, Aparicio L, Cheung LS, Lanis M, Belcaid Z, El Asmar M, Illei PB, Wang R, Meyers J, Schuebel K, Gupta A, Skaist A, Wheelan S, Naidoo J, Marrone KA, Brock M, Ha J, Bush EL, Park BJ, Bott M, Jones DR, Reuss JE, Velculescu VE, Chaft JE, Kinzler KW, Zhou S, Vogelstein B, Taube JM, Hellmann MD, Brahmer JR, Merghoub T, Forde PM, Yegnasubramanian S, Ji H, Pardoll DM, Smith KN.
PMID: 34608287
Nature. 2021 Oct;598(7881):E1. doi: 10.1038/s41586-021-03893-6.

No abstract available.

Cite
Caushi JX, Zhang J, Ji Z, et al. Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature. 2021;598(7881):E1doi: 10.1038/s41586-021-03893-6.
Caushi, J. X., Zhang, J., Ji, Z., Vaghasia, A., Zhang, B., Hsiue, E. H., Mog, B. J., Hou, W., Justesen, S., Blosser, R., Tam, A., Anagnostou, V., Cottrell, T. R., Guo, H., Chan, H. Y., Singh, D., Thapa, S., Dykema, A. G., Burman, P., Choudhury, B., Aparicio, L., Cheung, L. S., Lanis, M., Belcaid, Z., El Asmar, M., Illei, P. B., Wang, R., Meyers, J., Schuebel, K., Gupta, A., Skaist, A., Wheelan, S., Naidoo, J., Marrone, K. A., Brock, M., Ha, J., Bush, E. L., Park, B. J., Bott, M., Jones, D. R., Reuss, J. E., Velculescu, V. E., Chaft, J. E., Kinzler, K. W., Zhou, S., Vogelstein, B., Taube, J. M., Hellmann, M. D., Brahmer, J. R., Merghoub, T., Forde, P. M., Yegnasubramanian, S., Ji, H., Pardoll, D. M., & Smith, K. N. (2021). Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature, 598(7881), E1. https://doi.org/10.1038/s41586-021-03893-6
Caushi, Justina X, et al. "Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers." Nature vol. 598,7881 (2021): E1. doi: https://doi.org/10.1038/s41586-021-03893-6
Caushi JX, Zhang J, Ji Z, Vaghasia A, Zhang B, Hsiue EH, Mog BJ, Hou W, Justesen S, Blosser R, Tam A, Anagnostou V, Cottrell TR, Guo H, Chan HY, Singh D, Thapa S, Dykema AG, Burman P, Choudhury B, Aparicio L, Cheung LS, Lanis M, Belcaid Z, El Asmar M, Illei PB, Wang R, Meyers J, Schuebel K, Gupta A, Skaist A, Wheelan S, Naidoo J, Marrone KA, Brock M, Ha J, Bush EL, Park BJ, Bott M, Jones DR, Reuss JE, Velculescu VE, Chaft JE, Kinzler KW, Zhou S, Vogelstein B, Taube JM, Hellmann MD, Brahmer JR, Merghoub T, Forde PM, Yegnasubramanian S, Ji H, Pardoll DM, Smith KN. Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature. 2021 Oct;598(7881):E1. doi: 10.1038/s41586-021-03893-6. PMID: 34608287; PMCID: PMC8528690.
Copy Download .nbib Format: NLM
Traumatic iatrogenic chylothorax after external electrical cardioversion.

Respirology case reports

Ralli M, Justesen T, Frevert SC, Schultz ANØ.
PMID: 33304593
Respirol Case Rep. 2020 Dec 03;9(1):e00695. doi: 10.1002/rcr2.695. eCollection 2021 Jan.

Chylothorax, an uncommon cause of pleural effusion, results from the accumulation of lymph in the pleural space due to damage or obstruction of the thoracic duct. Chylothorax can be due to several aetiologies, many of which are rare, and...

Cite
Ralli M, Justesen T, Frevert SC, et al. Traumatic iatrogenic chylothorax after external electrical cardioversion. Respirol Case Rep. 2020;9(1):e00695doi: 10.1002/rcr2.695.
Ralli, M., Justesen, T., Frevert, S. C., & Schultz, A. N. �. �. (2021). Traumatic iatrogenic chylothorax after external electrical cardioversion. Respirology case reports, 9(1), e00695. https://doi.org/10.1002/rcr2.695
Ralli, Maria, et al. "Traumatic iatrogenic chylothorax after external electrical cardioversion." Respirology case reports vol. 9,1 (2021): e00695. doi: https://doi.org/10.1002/rcr2.695
Ralli M, Justesen T, Frevert SC, Schultz ANØ. Traumatic iatrogenic chylothorax after external electrical cardioversion. Respirol Case Rep. 2020 Dec 03;9(1):e00695. doi: 10.1002/rcr2.695. eCollection 2021 Jan. PMID: 33304593; PMCID: PMC7713552.
Copy Download .nbib Format: NLM
NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure.

Immunome research

Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S.
PMID: 21073747
Immunome Res. 2010 Nov 13;6:9. doi: 10.1186/1745-7580-6-9.

BACKGROUND: Binding of peptides to Major Histocompatibility class II (MHC-II) molecules play a central role in governing responses of the adaptive immune system. MHC-II molecules sample peptides from the extracellular space allowing the immune system to detect the presence...

Cite
Nielsen M, Justesen S, Lund O, et al. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res. 2010;6:9doi: 10.1186/1745-7580-6-9.
Nielsen, M., Justesen, S., Lund, O., Lundegaard, C., & Buus, S. (2010). NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome research, 69. https://doi.org/10.1186/1745-7580-6-9
Nielsen, Morten, et al. "NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure." Immunome research vol. 6 (2010): 9. doi: https://doi.org/10.1186/1745-7580-6-9
Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res. 2010 Nov 13;6:9. doi: 10.1186/1745-7580-6-9. PMID: 21073747; PMCID: PMC2994798.
Copy Download .nbib Format: NLM
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Journal for immunotherapy of cancer

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA, Brahmer JR, Pardoll DM, Anders RA, Housseau F.
PMID: 30841906
J Immunother Cancer. 2019 Mar 06;7(1):63. doi: 10.1186/s40425-019-0547-7.

.

Cite
Smith KN, Llosa NJ, Cottrell TR, et al. Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1. J Immunother Cancer. 2019;7(1):63doi: 10.1186/s40425-019-0547-7.
Smith, K. N., Llosa, N. J., Cottrell, T. R., Siegel, N., Fan, H., Suri, P., Chan, H. Y., Guo, H., Oke, T., Awan, A. H., Verde, F., Danilova, L., Anagnostou, V., Tam, A. J., Luber, B. S., Bartlett, B. R., Aulakh, L. K., Sidhom, J. W., Zhu, Q., Sears, C. L., Cope, L., Sharfman, W. H., Thompson, E. D., Riemer, J., Marrone, K. A., Naidoo, J., Velculescu, V. E., Forde, P. M., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., Durham, J. N., Wang, H., Le, D. T., Justesen, S., Taube, J. M., Diaz, L. A., Brahmer, J. R., Pardoll, D. M., Anders, R. A., & Housseau, F. (2019). Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1. Journal for immunotherapy of cancer, 7(1), 63. https://doi.org/10.1186/s40425-019-0547-7
Smith, Kellie N, et al. "Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1." Journal for immunotherapy of cancer vol. 7,1 (2019): 63. doi: https://doi.org/10.1186/s40425-019-0547-7
Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA, Brahmer JR, Pardoll DM, Anders RA, Housseau F. Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1. J Immunother Cancer. 2019 Mar 06;7(1):63. doi: 10.1186/s40425-019-0547-7. PMID: 30841906; PMCID: PMC6402146.
Copy Download .nbib Format: NLM
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.

Immunome research

Justesen S, Harndahl M, Lamberth K, Nielsen LL, Buus S.
PMID: 19416502
Immunome Res. 2009 May 05;5:2. doi: 10.1186/1745-7580-5-2.

BACKGROUND: Molecules of the class II major histocompability complex (MHC-II) specifically bind and present exogenously derived peptide epitopes to CD4+ T helper cells. The extreme polymorphism of the MHC-II hampers the complete analysis of peptide binding. It is also...

Cite
Justesen S, Harndahl M, Lamberth K, et al. Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res. 2009;5:2doi: 10.1186/1745-7580-5-2.
Justesen, S., Harndahl, M., Lamberth, K., Nielsen, L. L., & Buus, S. (2009). Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome research, 52. https://doi.org/10.1186/1745-7580-5-2
Justesen, Sune, et al. "Functional recombinant MHC class II molecules and high-throughput peptide-binding assays." Immunome research vol. 5 (2009): 2. doi: https://doi.org/10.1186/1745-7580-5-2
Justesen S, Harndahl M, Lamberth K, Nielsen LL, Buus S. Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res. 2009 May 05;5:2. doi: 10.1186/1745-7580-5-2. PMID: 19416502; PMCID: PMC2690590.
Copy Download .nbib Format: NLM
Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS.

Proteomics

Khan A, Shin JY, So MK, Na JH, Justesen S, Ansari AA, Ko BJ, Ahn SM.
PMID: 34561969
Proteomics. 2022 Jan;22(1):e2100171. doi: 10.1002/pmic.202100171. Epub 2021 Oct 05.

Human leukocyte antigen (HLA) class I has more than 18,000 alleles, each of which binds to a set of unique peptides from the cellular degradome. Deciphering the interaction between antigenic peptides and HLA proteins is crucial for understanding immune...

Cite
Khan A, Shin JY, So MK, et al. Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics. 2021;22(1):e2100171doi: 10.1002/pmic.202100171.
Khan, A., Shin, J. Y., So, M. K., Na, J. H., Justesen, S., Ansari, A. A., Ko, B. J., & Ahn, S. M. (2022). Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics, 22(1), e2100171. https://doi.org/10.1002/pmic.202100171
Khan, Amir, et al. "Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS." Proteomics vol. 22,1 (2022): e2100171. doi: https://doi.org/10.1002/pmic.202100171
Khan A, Shin JY, So MK, Na JH, Justesen S, Ansari AA, Ko BJ, Ahn SM. Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MS. Proteomics. 2022 Jan;22(1):e2100171. doi: 10.1002/pmic.202100171. Epub 2021 Oct 05. PMID: 34561969.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries